keyword
https://read.qxmd.com/read/38721789/bowel-emergencies-in-patients-with-cancer
#21
REVIEW
Hannah Hughes, Ankush Jajodia, Philippe Soyer, Vincent Mellnick, Michael N Patlas
Cancer is the second most common cause of death worldwide. Bowel emergencies in patients with cancer are becoming increasingly more prevalent due to advances in cancer therapy and longer overall patient survival. When these patients present acutely, they are often frail and may have pre-existing co-morbidities. This article discusses the imaging features of bowel emergencies commonly encountered in oncological patients in clinical practice. These include chemotherapy related colitis, neutropenia enterocolitis and typhlitis, toxic megacolon, bowel perforation, malignant bowel obstruction and gastrointestinal haemorrhage...
May 9, 2024: Canadian Association of Radiologists Journal
https://read.qxmd.com/read/38721556/neuromyelitis-optica-spectrum-disorder-co-existing-with-antiphospholipid-syndrome-a-case-report
#22
Gidion Edwin, Francis Msagati, Francisca Komanya, Baraka Alphonce, John Meda, Azan Nyundo
KEY CLINICAL MESSAGE: Neuromyelitis optica spectrum disorder is an autoimmune disease, rarely presents with antiphospholipid syndrome. Diagnosis and management of NMOSD are challenging in the background of diverse presentations, especially in resource-limited settings. ABSTRACT: Neuromyelitis optica spectrum disorder (NMOSD) is a progressive demyelinating autoimmune condition resulting from the autoantibodies produced against aquaporin-4 (AQP-4) proteins which are widely distributed in astrocytes in the nervous system...
May 2024: Clinical Case Reports
https://read.qxmd.com/read/38721554/a-case-of-cytomegalovirus-colitis-initially-misdiagnosed-as-colonic-ischemia-in-an-immunocompetent-japanese-woman
#23
Atsuro Hamano, Shunsuke Harada, Takaaki Kobayashi, Sandra Moody, Akihito Yoshida
Cytomegalovirus colitis should be considered in a patient presenting with bloody stool even among immunocompetent patients.
May 2024: Clinical Case Reports
https://read.qxmd.com/read/38721342/investigating-shared-genetic-architecture-between-inflammatory-bowel-diseases-and-primary-biliary-cholangitis
#24
JOURNAL ARTICLE
Wentao Huang, Rui Jiang, Sitao Li, Ruijie Zeng, Yang Li, Yajie Zhang, Shuangshuang Tong, Yanlin Lyu, Jiaxuan Wang, Qizhou Lian, Felix W Leung, Ruibang Luo, Weihong Sha, Hao Chen
BACKGROUND & AIMS: Inflammatory bowel disease (IBD) is commonly associated with extraintestinal complications, including autoimmune liver disease. The co-occurrence of IBD and primary biliary cholangitis (PBC) has been increasingly observed, but the underlying relationship between these conditions remains unclear. METHODS: Using summary statistics from genome-wide association studies (GWAS), we investigated the causal effects between PBC and IBD, including Crohn's disease (CD) and ulcerative colitis (UC)...
June 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38721168/a-case-report-of-refractory-graft-versus-host-disease-colitis-managed-with-robotic-total-abdominal-colectomy
#25
Olivia Ziegler, Neekita R Jikaria, Joseph Cioccio, Jeffery S Scow
Graft-versus-host disease (GvHD) is a common complication following hematopoietic stem cell transplant (HSCT) and has protean manifestations. It results from the activation of transplanted T lymphocytes against the HLA antigens of recipient cells, resulting in tissue destruction. The most commonly involved sites of acute GvHD are the skin and gut, with high mortality reported in the latter. Historically, surgery for gut GvHD has been reserved for those with frank perforations or uncontrolled hemorrhage. Here, we present a case of steroid and ruxolitinib refractory colonic GvHD in a 41-year-old female, which was ultimately managed with robotic-assisted total abdominal colectomy with resolution of enteric symptoms...
April 2024: Curēus
https://read.qxmd.com/read/38720936/strategies-for-enhancing-inflammatory-bowel-disease-care-in-pakistan-bridging-gaps-and-building-capacities
#26
EDITORIAL
Jalpa Devi, Parakkal Deepak, Amna Subhan Butt
No abstract text is available yet for this article.
April 2024: Crohn's & colitis 360
https://read.qxmd.com/read/38720935/clinical-decision-making-in-inflammatory-bowel-disease-mimics-practice-management-from-inflammatory-bowel-disease-live
#27
JOURNAL ARTICLE
Hannah W Fiske, Christopher Ward, Samir A Shah, Stefan D Holubar, Badr Al-Bawardy, Edward L Barnes, David Binion, Matthew Bohm, Myron Brand, Kofi Clarke, Benjamin L Cohen, Raymond K Cross, Jeffrey Dueker, Michael Engels, Francis A Farraye, Sean Fine, Erin Forster, Jill Gaidos, Philip Ginsburg, Alka Goyal, John Hanson, Hans Herfath, Tracy Hull, Colleen R Kelly, Mark Lazarev, L Campbell Levy, Joanna Melia, Jessica Philpott, Taha Qazi, Corey A Siegel, Andrew Watson, Steven D Wexner, Emmanuelle D Williams, Miguel Regueiro
BACKGROUND: Since 2009, inflammatory bowel disease (IBD) specialists have utilized "IBD LIVE," a weekly live video conference with a global audience, to discuss the multidisciplinary management of their most challenging cases. While most cases presented were confirmed IBD, a substantial number were diseases that mimic IBD. We have categorized all IBD LIVE cases and identified "IBD-mimics" with consequent clinical management implications. METHODS: Cases have been recorded/archived since May 2018; we reviewed all 371 cases from May 2018-February 2023...
April 2024: Crohn's & colitis 360
https://read.qxmd.com/read/38720886/causal-relationship-between-eosinophilic-esophagitis-and-inflammatory-bowel-disease-a-bidirectional-two-sample-mendelian-randomization-study
#28
JOURNAL ARTICLE
Ruoyu Ji, Yuxiang Zhi
BACKGROUND: Eosinophilic esophagitis (EoE) and inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC), are immune-mediated gastrointestinal diseases with overlapped pathogenesis and are sometimes concurrently diagnosed, but their causal relationship remains unclear. We investigated the causal relationship between EoE and IBD and its subtypes via a two-sample bidirectional Mendelian randomization (MR) approach. METHODS: MR analyses were performed using summary data of a genome-wide association study (GWAS) on individuals of European ancestry...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38720628/fecal-transplantation-for-ulcerative-colitis-from-diet-conditioned-donors-followed-by-dietary-intervention-results-in-favorable-gut-microbial-profile-compared-to-fecal-transplantation-alone
#29
JOURNAL ARTICLE
Haim Leibovitzh, Chen Sarbagili Shabat, Ayal Hirsch, Eran Zittan, Maria Chiara Mentella, Valentina Petito, Nathaniel Aviv Cohen, Yulia Ron, Naomi Fliss Isakov, Jorge Pfeffer, Michal Yaakov, Caterina Fanali, Laura Turchini, Luca Masucci, Gianluca Quaranta, Nitzan Kolonimos, Anastasia Godneva, Adina Weinberger, Franco Scaldaferri, Nitsan Maharshak
BACKGROUND AND AIMS: Several fecal microbial transplantation (FMT) approaches for ulcerative colitis (UC) have been investigated with conflicting results. We have recently published the clinical outcomes from the CRAFT-UC Trial using FMT with the UC Exclusion Diet (UCED), compared with FMT alone. Here we aimed to compare the two FMT strategies in terms of microbial profile and function. METHODS: Subjects recruited to the CRAFT-UC study with available pre- and post-intervention fecal samples were included...
May 9, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38720520/polyphenolic-nanoparticle-modified-probiotics-for-microenvironment-remodeling-and-targeted-therapy-of-inflammatory-bowel-disease
#30
JOURNAL ARTICLE
Qinglian Hu, Jingyu Li, Tong Wang, Xiangchi Xu, Yuxuan Duan, Yuanxiang Jin
Inflammatory bowel diseases (IBDs) refer to multifaceted disorders in the intestinal microenvironment and microbiota homeostasis. In view of the broad bioactivity and high compatibility of polyphenols, there is considerable interest in developing a polyphenol-based collaborative platform to remodel the IBD microenvironment and regulate microbiota. Here, we demonstrated the coordination assembly of nanostructured polyphenols to modify probiotics and simultaneously deliver drugs for IBD treatment. Inspired by the distinctive structure of tannic acid (TA), we fabricated nanostructured pBDT-TA by using a self-polymerizable aromatic dithiol (BDT) and TA, which exhibited excellent antioxidant and anti-inflammatory capability in vitro ...
May 8, 2024: ACS Nano
https://read.qxmd.com/read/38720466/efficacy-and-safety-of-mirikizumab-as-induction-and-maintenance-therapy-for-japanese-patients-with-moderately-to-severely-active-ulcerative-colitis-a-subgroup-analysis-of-the-global-phase-3-lucent-1-and-lucent-2-studies
#31
JOURNAL ARTICLE
Taku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, Tadakazu Hisamatsu, Fumihito Hirai, Joe Milata, Xingyuan Li, Nathan Morris, Vipin Arora, Tomoko Ishizuka, Koji Matsuo, Yoichi Satoi, Catherine Milch, Toshifumi Hibi
BACKGROUND/AIMS: Mirikizumab is a p19-directed anti-interleukin-23 antibody with potential efficacy against ulcerative colitis (UC). We evaluated the efficacy and safety of mirikizumab in a Japanese subpopulation with moderately to severely active UC from the LUCENT-1 and LUCENT-2 studies. METHODS: LUCENT-1 and LUCENT-2 were phase 3, randomized, double-blind, placebo-controlled trials of mirikizumab therapy in adults with moderately to severely active UC. LUCENT-1 was a 12-week induction trial where patients were randomized 3:1 to receive intravenous mirikizumab 300 mg or placebo every 4 weeks (Q4W)...
April 2024: Intestinal Research
https://read.qxmd.com/read/38720202/the-powerful-potential-of-amino-acid-menthyl-esters-for-anti-inflammatory-and-anti-obesity-therapies
#32
JOURNAL ARTICLE
Seidai Takasawa, Kosuke Kimura, Masato Miyanaga, Takuya Uemura, Masakazu Hachisu, Shinichi Miyagawa, Abdelaziz Ramadan, Satoru Sukegawa, Masaki Kobayashi, Seisuke Kimura, Kenji Matsui, Mitsunori Shiroishi, Kaori Terashita, Chiharu Nishiyama, Takuya Yashiro, Kazuki Nagata, Yoshikazu Higami, Gen-Ichiro Arimura
Our newly developed menthyl esters of valine and isoleucine exhibit anti-inflammatory properties beyond those of the well-known menthol in macrophages stimulated by lipopolysaccharide (LPS) and in a mouse model of colitis induced by sodium dextran sulfate. Unlike menthol, which acts primarily through the cold-sensitive TRPM8 channel, these menthyl esters displayed unique mechanisms that operate independently of this receptor. They readily penetrated target cells and efficiently suppressed LPS-stimulated tumour necrosis factor-alpha (Tnf) expression mediated by liver X receptor (LXR), a key nuclear receptor that regulates intracellular cholesterol and lipid balance...
May 8, 2024: Immunology
https://read.qxmd.com/read/38720063/neutrophil-derived-pad4-induces-citrullination-of-ckmt1-exacerbates-mucosal-inflammation-in-inflammatory-bowel-disease
#33
JOURNAL ARTICLE
Shuling Wang, Yihang Song, Zhijie Wang, Xin Chang, Haicong Wu, Ziwei Yan, Jiayi Wu, Zixuan He, Le Kang, Wenjun Hu, Tian Xia, Zhaoshen Li, Xingxing Ren, Yu Bai
Peptidyl arginine deiminase 4 (PAD4) plays a pivotal role in infection and inflammatory diseases by facilitating the formation of neutrophil extracellular traps (NETs). However, the substrates of PAD4 and its exact role in inflammatory bowel disease (IBD) remain unclear. In this study, we employed single-cell RNA sequencing (scRNA-seq) and substrate citrullination mapping to decipher the role of PAD4 in intestinal inflammation associated with IBD. Our results demonstrated that PAD4 deficiency alleviated colonic inflammation and restored intestinal barrier function in a dextran sulfate sodium (DSS)-induced colitis mouse model...
May 8, 2024: Cellular & Molecular Immunology
https://read.qxmd.com/read/38719549/effects-of-prednisolone-tapering-on-effectiveness-of-infliximab-in-patients-with-ulcerative-colitis-data-from-a-retrospective-cohort
#34
JOURNAL ARTICLE
Pernille Dige Ovesen, Mohamed Attauabi, Johan F K F Ilvemark, Mads Damsgaard Wewer, David J Warren, Johan Burisch, Rolf A Klaasen, Nils Bolstad, Casper Steenholdt, Jakob Benedict Seidelin
BACKGROUND AND OBJECTIVE: The influence of concomitant prednisolone on clinical outcomes and safety in infliximab-treated ulcerative colitis (UC) patients is unknown. DESIGN, SETTING, PARTICIPANTS AND OUTCOME MEASURES: A retrospective cohort study was performed, including 147 UC patients treated with infliximab at a tertiary inflammatory bowel disease (IBD) centre. Primary outcome was corticosteroid-free clinical remission (CFCR) at week 14 and week 52. Patients were grouped according to prednisolone tapering regimens: standard (≤5 mg/week), fast (>5 mg/week), direct discontinuation or no prednisolone...
May 7, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38719255/immune-checkpoint-inhibitor-associated-diarrhoea
#35
JOURNAL ARTICLE
Amin Al-Hussainy, Joss Adams, Jon Simmons, James Kennedy
A man in his 80s was undergoing immunotherapy with pembrolizumab, an anti-PD-1 monoclonal antibody, following his diagnosis of adenocarcinoma of primary lung origin. 24 weeks into treatment, the patient reported experiencing loose stools associated with malaise and poor appetite but no further symptoms. This progressed in frequency and a clinical diagnosis of grade 2 immune checkpoint inhibitor colitis was made. Management with oral prednisolone was commenced but symptoms persisted. Common enteric infections had been ruled out, as were coeliac disease and hyperthyroidism...
May 8, 2024: BMJ Case Reports
https://read.qxmd.com/read/38719182/assessment-of-the-quality-of-life-of-patients-with-inflammatory-bowel-disease
#36
JOURNAL ARTICLE
María Del Mar Calvo Bernal, Elena Pérez Campos, Adrián Aparicio Mota, Álvaro Hernández Martínez
INTRODUCTION: Ulcerative colitis (UC) and Crohn's disease (CD) are diseases that cause a significant impact on patients' quality of life.The aim of this study is to assess the impact of inflammatory bowel disease (IBD) on health-related quality of life (HRQoL). MATERIAL AND METHODS: Observational, descriptive, cross-sectional study, carried out at Torrecárdenas Hospital (Almería). Patients over 14 years of age diagnosed with CD or UC were included.For the assessment of HRQoL, the reduced 9-item IBDQ-9 questionnaire was used...
May 6, 2024: Gastroenterología y Hepatología
https://read.qxmd.com/read/38718992/orally-ingestible-medication-utilizing-layered-double-hydroxide-nanoparticles-strengthened-alginate-and-hyaluronic-acid-based-hydrogel-bead-for-bowel-disease-management
#37
JOURNAL ARTICLE
Ngoc Tuan Nguyen, Bich-Phuong Thi Nguyen, Tuyet-Nhung Ho, Cam-Nhung Dinh Tran, Thanh-Han Hoang Tran, Hoai-Phong Huu Nguyen, Hong-Phuc Nguyen, Ngoc-Thuy Huynh, Yi Li, V H Giang Phan, Thavasyappan Thambi
In the treatment of bowel diseases such as ulcerative colitis through oral administration, an effective drug delivery system targeting the colon is crucial for enhancing efficacy and minimizing side effects of therapeutic agents. This study focuses on the development of a novel nanocomposite hydrogel bead comprising a synergistic blend of biological macromolecules, namely sodium alginate (ALG) and hyaluronic acid (HA), reinforced with layered double hydroxide nanoparticles (LDHs) for the oral delivery of dual therapeutics...
May 6, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38718985/characterization-of-shiga-toxin-producing-escherichia-coli-isolated-from-cattle-around-ulaanbaatar-city-mongolia
#38
JOURNAL ARTICLE
Erdenebat Bulgan, Zolzaya Byambajav, Narantuya Ayushjav, Yuji Hirai, Misaki Tanaka, Nyam-Osor Purevdorj, Sandagdorj Badrakh, Akio Suzuki, Yusuke Komatsu, Toyotaka Sato, Motohiro Horiuchi
Shiga toxin-producing Escherichia coli (STEC) are associated with severe infections including hemorrhagic colitis and hemolytic uremic syndrome in humans. Ruminants are known as reservoirs of STEC; however, no data are available on STEC in ruminants in Mongolia, where more than 5 million cattle and 25 million sheep are raised. To disclose the existence and characteristics of STEC in Mongolia, in this study, we isolated and characterized STEC from cattle in Mongolia. We collected 350 rectal swabs of cattle from 30 farms near Ulaanbaatar city and isolated 45 STEC from 21 farms...
May 6, 2024: Journal of Food Protection
https://read.qxmd.com/read/38718808/-not-available
#39
JOURNAL ARTICLE
T Kucharzik, A Dignass, R Atreya, B Bokemeyer, P Esters, K Herrlinger, K Kannengiesser, P Kienle, J Langhorst, A Lügering, S Schreiber, A Stallmach, J Stein, A Sturm, N Teich, B Siegmund
No abstract text is available yet for this article.
May 2024: Zeitschrift Für Gastroenterologie
https://read.qxmd.com/read/38718807/-not-available
#40
JOURNAL ARTICLE
Pia Lorenz, Axel Dignass, Torsten Kucharzik, Petra Lynen Jansen
No abstract text is available yet for this article.
May 2024: Zeitschrift Für Gastroenterologie
keyword
keyword
1291
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.